WHAM: Wellness Health & Medicine

25/02/2026

HIMSS 2026 at Las Vegas

This article provides a strategic deep dive into HIMSS26, the world’s premier health information technology summit, where the global medical community shifts from experimental AI to scalable, enterprise-wide integration. It serves as a roadmap for healthcare leaders navigating the convergence of digital infrastructure, sovereign data security, and the future of physician-patient interactions.

Check out the full article by clicking here...

From Hype to Hardwire: Scaling the Digital Backbone of Global Health

17/02/2026

National Cancer Prevention: A Tribute to Resilience and Precision

In 2026, National Cancer Prevention Month transcends basic lifestyle advice, focusing on the rising tide of early-onset malignancies and the integration of precision diagnostics.

While 40–50% of cancers remain preventable through modifiable factors—namely adiposity, to***co, and alcohol—epidemiological shifts reveal a 30% projected increase in "young-onset" cases by 2030. Clinical focus has pivoted toward risk-stratified screening and the emergence of Multi-Cancer Early Detection (MCED) liquid biopsies.

For medical professionals, the mandate is clear: move beyond age-based silos to address molecular drivers like chronic inflammation and microbiome dysbiosis. This article synthesizes current AACR/ACS guidelines, molecular oncogenesis, and the "WHAM" framework to empower clinicians in the proactive mitigation of the global cancer burden.

Click for Full article here:

February 2026: National Cancer Prevention Month

16/02/2026

The Silent Thief of Sight: AMD
From Neural Degeneration to Genomic Hope: A Comprehensive Guide to Protecting Your Central Vision

Each February, during Age-Related Macular Degeneration (AMD) and Low Vision Awareness Month, clinicians and public health leaders refocus attention on a disease that rarely causes pain, often progresses quietly, and remains one of the leading causes of irreversible central vision loss in adults over 50.

AMD affects nearly 20 million people in the United States, with approximately 1.5–1.8 million living with advanced forms (geographic atrophy or neovascular AMD). Globally, prevalence is projected to exceed 280 million by 2040 as populations age. While the “dry” form accounts for 80–90% of cases, the “wet” (neovascular) form is responsible for the majority of severe, rapid central vision loss.

Yet the 2026 landscape is not defined by inevitability — it is defined by intervention. With the maturation of high-dose anti-VEGF therapies such as Eylea HD and dual-pathway agents like Vabysmo, alongside the first FDA-approved complement inhibitors for geographic atrophy — Syfovre and Izervay — ophthalmology has entered its most transformative decade. Investigational gene therapies such as RGX-314 are pushing the boundaries further, seeking sustained intraocular anti-VEGF production from a single procedure.

AMD is no longer a passive diagnosis. It is an actively managed chronic retinal disease — provided it is detected early and treated appropriately.

Click here for full article....

From Neural Degeneration to Genomic Hope: A Comprehensive Guide to Protecting Your Central Vision

16/02/2026

From Neural Degeneration to Genomic Hope: A Comprehensive Guide to Protecting Your Central Vision

05/02/2026

THE PILL REVOLUTION

Forget the "Ozempic Face"—2026 is officially the year of the Metabolic Pill. 💊 We’re moving from weekly needles to daily tablets like Orforglipron, with new "Triple Agonists" promising surgical-level weight loss without the surgery.

Ready to see how the next generation of biotech is rewriting the rules of human health? 🧬✨
Read the full deep-dive here:

https://wellnesshealthandmedicine.substack.com/p/the-pill-revolution-engineering-the

From Incretin Injections to Oral Autonomy: Inside the 2026 Metabolic Pipeline

03/02/2026

World Cancer Day Feb 04:

Mapping the Breakthroughs in Patient Autonomy, AI Prediction, and Liquid Biopsy

World Cancer Day 2026 arrives as oncology undergoes a seismic transition from population-based protocols to n-of-1 precision care. Under the UICC banner “United by Unique,” the focus has shifted from “the tumor” to “the person.”

This transition is fueled by three technological pillars: Subcutaneous Immunotherapy, which compresses grueling hour-long IV infusions into 7-minute injections to prioritize patient quality of life; MIT’s Sybil AI, which identifies lung cancer risk six years before physical nodules manifest; and Multi-Cancer Early Detection (MCED) blood tests, which screen for 50+ cancer types from a single vial.

These innovations are dismantling traditional hospital-tethered models, offering a future where cancer is managed with foresight rather than reaction. By placing individual stories and needs at the heart of health systems, we move toward a future where “personalized medicine” is a logistical reality for all, not just a clinical aspiration for the few.

Full article at:

World Cancer Day Feb 04: Mapping the Breakthroughs in Patient Autonomy, AI Prediction, and Liquid Biopsy

03/02/2026

The wait for a kidney transplant could soon be history! 🧬✨

Imagine biological independence without being tethered to a machine. From implantable silicon kidneys that work without drugs to gene-edited organs and wearable dialysis, 2026 is officially the year science fiction becomes medical reality.

We’re closing the transplant gap for good. Are you ready for the future of renal health?

Read the full story here:
https://wellnesshealthandmedicine.substack.com/p/the-kidney-frontier-from-mechanical

Mapping latest Breakthroughs in Artificial Organs and Xenotransplantation

01/02/2026

Is the internal "Second Genome" the missing piece of the medical puzzle?

Just wrapped up the highlights from the Microbiome Summit 2026 in Hong Kong. We are moving past the "observation phase" into an era of Metagenomic Engineering. >

🚀 Key Takeaways:

AI-Powered Diagnostics: MSX Metagenie® is now ruling out Autism risk with 95% accuracy using a simple stool sample.

Smart Biomaterials: New pH-responsive coatings are delivering live bacteria to the colon with 90% survival rates.

MOZAIC™ Tech: AI is now "matching" gut ecosystems like a biological dating app for transplants.

The gut isn't just for digestion anymore—it's a programmable organ. Check out the full deep-dive on my Substack:

https://wellnesshealthandmedicine.substack.com/p/the-second-genome-revolution-inside

Deciphering the Multi-Kingdom Code and the Rise of Microbial Engineering

27/01/2026

Nipah Virus, January 2026:
Why a Handful of Cases Is Enough to Trigger a Global Alert

From West Bengal to World Airports — Understanding the Science, the Risk, and the Right Response

A small cluster of Nipah virus infections in eastern India has once again triggered global public-health vigilance. Airports across Asia are reintroducing COVID-era screening measures, neighbouring countries are enhancing surveillance, and international media coverage is intensifying.

To many readers, this reaction may seem disproportionate. How can a virus with only a few confirmed cases command such attention?

Read full article here:

From West Bengal to World Airports — Understanding the Science, the Risk, and the Right Response